GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Policy Acquisition Expense

Argenica Therapeutics (ASX:AGN) Policy Acquisition Expense


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Argenica Therapeutics (ASX:AGN) Business Description

Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.